References
- Renal Data System: USRDS 1998 Annual Data Report (NIH Publ No 98-3176). Washington, DC: US Government Printing Office; 1998.
- Isermann B, Vinnikov IA, Madhusudhan T, Herzog S, Kashif M, Blautzik J, Activated protein C protects against diabetic nephropathy by inhibiting endothelial and podocyte apoptosis. Nat Med 2007;13:1349–58.
- Beyenbach KW. Kidneys sans glomeruli. Am J Physiol Renal Physiol 2004;286:F811–27.
- Nakamura T, Nishizawa T, Hagiya M, Seki T, Shimonishi M, Sugimura A, Molecular cloning and expression of human hepatocyte growth factor. Nature 1989;342:440–3.
- Matsumoto K, Nakamura T. Hepatocyte growth factor: renotropic role and potential therapeutics for renal diseases. Kidney Int 2001;59:2023–38.
- Detrisac CJ, Sens MA, Garvin AJ, Spicer SS, Sens DA. Tissue culture of human kidney epithelial cells of proximal tubule origin. Kidney Int 1984;25:383–90.
- Akmal M. Hemodialysis in diabetic patients. Am J Kidney Dis 2001;38:S195–9.
- Yamamoto T, Nakamura T, Noble NA, Ruoslahti E, Border WA. Expression of transforming growth factor beta is elevated in human and experimental diabetic nephropathy. Proc Natl Acad Sci USA 1993;90:1814–8.
- Taylor GA, Jeffers M, Webb CP, Koo HM, Anve M, Sekiguchi K, Vande-Woude GF. Decreased fibronectin expression in Met/HGF-mediated tumorigenesis. Oncogene 1998;17:1179–83.
- Mizuno S, Nakamura TSuppressions of chronic glomerular injuries and TGF-β1 production by HGF in attenuation of murine diabetic nephropathy. Am J Physiol Renal Physiol 2004;286:F134–43.
- Dworkin LD, Gong RJ, Tolbert E, Centracchio J, Yano N, Zanabli A, Hepatocyte growth factor ameliorates progression of interstitial fibrosis in rats with established renal injury. Kidney Int 2004;65:409–19.
- Mizuno S, Matsumoto K, Kurosawa T, Mizuno-Horikawa Y, Nakamura T. Reciprocal balance of hepatocyte growth factor and transforming growth factor-beta 1 in renal fibrosis in mice. Kidney Int 2000;57:937–48.
- Schelling JR, Cleveland RP. Involvement of Fas-dependent apoptosis in renal tubular epithelial cell deletion in chronic renal failure. Kidney Int 1999;56:1313–6.
- Fornoni, Li H, Foschi A, Striker GE, Striker LJ. Hepatocyte growth factor, but not insulin-like growth factor I, protects podocytes against cyclosporine A-induced apoptosis. Am J Pathol 2001;158:275–80.
- Liu Y, Sun AM, Dworkin LD. Hepatocyte growth factor protects renal epithelial cells from apoptotic cell death. Biochem Biophys Res Commun 1998;246:821–6.
- Ziyadeh FN. Significance of tubulointerstitial changes in diabetic renal disease. Kidney Int 1996;49(Suppl 54):S10–3.
- Taniyama Y, Morishita R, Nakagami H, Moriguchi A, Sakonjo H, Shokei-Kim, Potential contribution of a novel antifibrotic factor, hepatocyte growth factor, to prevention of myocardial fibrosis by angiotensin II blockade in cardiomyopathic hamsters. Circulation 2000;102:246–52.